Alzheimer Disease
Showing NaN - NaN of 61
Alzheimer, Cognitive Dysfunction, Dementia Trial in Worldwide (JNJ-63733657, Placebo)
Recruiting
- Alzheimer Disease
- +2 more
- JNJ-63733657
- Placebo
-
Birmingham, Alabama
- +143 more
Jan 31, 2023
Alzheimer's Disease Treatment With Combination of 40Hz Light and
Recruiting
- Alzheimer Disease
- +5 more
- Combination of 40Hz light and cognitive therapy (ALZLIFE)
-
Miami, FloridaAndrey Vyshedskiy
Jan 31, 2023
Alzheimer, Alzheimer 1, Alzheimer 2 Trial in United States (Sensory Stimulation System (GS120) - Active, Sensory Stimulation
Recruiting
- Alzheimer Disease
- +34 more
- Sensory Stimulation System (GS120) - Active
- Sensory Stimulation System (GS120) - Sham
-
Washington, District of Columbia
- +24 more
Jan 27, 2023
The Diabetes Prevention Program Outcomes Study AD/ADRD Project
Enrolling by invitation
- Diabetes
- +4 more
-
Phoenix, Arizona
- +26 more
Jan 19, 2023
Alzheimer Trial in United States (15mg T3D-959, 30 mg T3D-959, 45 mg T3D-959)
Active, not recruiting
- Alzheimer Disease
- 15mg T3D-959
- +3 more
-
Phoenix, Arizona
- +41 more
Jan 23, 2023
Mild Cognitive Impairment, Alzheimer Trial in United States (Donanemab, Aducanumab)
Active, not recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
-
Fullerton, California
- +30 more
Jan 18, 2023
Alzheimer Trial in Worldwide (LY3372689, Placebo)
Active, not recruiting
- Alzheimer Disease
- LY3372689
- Placebo
-
Canoga Park, California
- +70 more
Jan 18, 2023
Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation,Psychomotor Trial in Canada, United States
Completed
- Agitation in Patients With Dementia of the Alzheimer's Type
- +2 more
- AXS-05
- Placebo
-
Sun City, Arizona
- +62 more
Dec 13, 2022
Healthy, Alzheimer Trial in United States (Lu AF87908, Placebo)
Recruiting
- Healthy
- Alzheimer Disease
- Lu AF87908
- Placebo
-
Glendale, California
- +5 more
Dec 13, 2022
Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation Trial in United States (AXS-05, Placebo)
Recruiting
- Agitation in Patients With Dementia of the Alzheimer's Type
- +2 more
- AXS-05
- Placebo
-
Peoria, Arizona
- +22 more
Dec 12, 2022
Alzheimer, Dementia Trial in New York (DREEM 2 Headband, Fitbit)
Not yet recruiting
- Alzheimer Disease
- Dementia
- DREEM 2 Headband
- Exercise Routine
-
Miami, FloridaUniversity of Miami Hospitals
Dec 5, 2022
Neurocognitive Disorders, Alzheimer, Caregiver Trial in Birmingham, Miami (CareHeroes)
Not yet recruiting
- Neurocognitive Disorders
- +2 more
- CareHeroes
-
Birmingham, Alabama
- +1 more
Oct 5, 2022
Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation, Psychomotor Trial in United States (AXS-05
Enrolling by invitation
- Agitation in Patients With Dementia of the Alzheimer's Type
- +2 more
- AXS-05 (dextromethorphan-bupropion)
-
Lafayette, California
- +26 more
Sep 29, 2022
Alzheimer, Mild Cognitive Impairment Trial in United States (Florbetapir F 18 PET Scan)
Active, not recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
- Florbetapir F 18 PET Scan
-
Anaheim, California
- +76 more
Sep 21, 2022
Database to Investigate Blood-Based and Digital Biomarkers in
Recruiting
- Alzheimer Disease
- +5 more
- Biomarker Data Collection
-
Aventura, Florida
- +15 more
Sep 21, 2022
Alzheimer Trial in Miami (Approximately 100 million cells allogeneic hMSC)
Active, not recruiting
- Alzheimer Disease
- Approximately 100 million cells allogeneic hMSC
-
Miami, FloridaUniversity of Miami
Aug 15, 2022
Alzheimer Trial in United States (Blood Brain Barrier (BBB) Disruption)
Recruiting
- Alzheimer Disease
- Blood Brain Barrier (BBB) Disruption
-
Delray Beach, Florida
- +6 more
Jul 11, 2022
Alzheimer Trial in Worldwide (Gantenerumab, Placebo)
Active, not recruiting
- Alzheimer Disease
- Gantenerumab
- Placebo
-
Phoenix, Arizona
- +156 more
Jul 4, 2022